These results indicate that IL-4 is produced by TOX+ CD4+ T cells in the skin lesions of CTCL patients and that the clonal expansion of these cells provides a Th2 cytokine milieu at early stages of the disease. The gene discussed is CD4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.